+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tobramycin"

Aminoglycosides Global Market Report 2024 - Product Thumbnail Image

Aminoglycosides Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
Global and Chinese Tobramycin Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Tobramycin Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 139 Pages
  • China, Global
From
From
2021 Tobramycin Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2021 Tobramycin Test Volume and Sales Segment Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • March 2021
  • Japan, United States, ... Japan, United States, Europe
From
2020 Tobramycin Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Tobramycin Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Japan, United States, ... Japan, United States, Europe
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Tobramycin is an aminoglycoside antibiotic used to treat a variety of bacterial infections. It is commonly used to treat respiratory tract infections, urinary tract infections, and skin and soft tissue infections. Tobramycin is also used to treat certain types of meningitis and sepsis. It is usually administered intravenously or intramuscularly, and is available in both generic and branded forms. Tobramycin is a widely used antibiotic, and is often used in combination with other antibiotics to treat more serious infections. It is generally well tolerated, with few side effects. However, it can cause nephrotoxicity and ototoxicity, and should be used with caution in patients with renal impairment. The tobramycin market is highly competitive, with a number of companies offering branded and generic versions of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and Mylan. Show Less Read more